Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Two-stage evaluation of lenalidomide (Revlimid) in late-relapse ovarian cancer
2008-007497-37Phase 2Completed
- Sponsor
- ARCAGY
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of lenalidomide in ovarian cancer (2 arms), sponsored by ARCAGY. Primary endpoint: Stage A primary efficacy endpoint. Started Mar 2009; status: completed.
02
Drugs
lenalidomide
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on 2008-007497-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007497-37.